Share Price and Basic Stock Data
Last Updated: December 18, 2025, 10:28 pm
| PEG Ratio | -100.71 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
UltraTech Cement Ltd, a leading player in India’s cement industry, has demonstrated robust performance in recent years. The company reported a staggering revenue of ₹63,240 Cr for FY 2023, which is a significant increase from ₹52,599 Cr in FY 2022. This upward trajectory continued into FY 2024, with sales expected to rise to ₹70,908 Cr. The last few quarters reflect a strong sales pattern, with revenues peaking at ₹20,419 Cr in Q4 FY 2024. However, the sales figures for Q2 FY 2025, at ₹21,275 Cr, indicate some fluctuations, suggesting potential seasonality in demand or market conditions. Despite these variances, the overall trend remains positive, showcasing UltraTech’s ability to capture market share effectively.
Profitability and Efficiency Metrics
Profitability metrics for UltraTech Cement present a mixed picture. The company’s operating profit margin (OPM) stood at 17% for FY 2025, slightly lower than the 22% recorded in FY 2022. This decline could be attributed to rising input costs and competitive pricing pressures in the industry. Net profit for FY 2025 is reported at ₹6,884 Cr, reflecting a decline from ₹7,334 Cr in FY 2022. However, the interest coverage ratio (ICR) of 8.06x indicates that UltraTech is comfortably managing its debt obligations, which is a reassuring sign for investors. The return on equity (ROE) of 9.29% and return on capital employed (ROCE) at 10.9% suggest that while profitability is under pressure, the company still maintains reasonable efficiency in utilizing its capital.
Balance Sheet Strength and Financial Ratios
UltraTech’s balance sheet exhibits notable strength, with total borrowings increasing to ₹24,102 Cr. This rise in debt could be a strategic move to fund expansion initiatives, as evidenced by the significant increase in fixed assets, which stood at ₹94,564 Cr in FY 2025. The company’s reserves also reflect healthy growth, reaching ₹70,412 Cr, which adds a layer of financial stability. The price-to-book value ratio of 4.79x suggests that the stock may be trading at a premium compared to its book value, indicating market confidence in its future growth. However, the current ratio of 0.73x raises some concerns about short-term liquidity, suggesting that the company might face challenges in meeting its short-term obligations.
Shareholding Pattern and Investor Confidence
Investor confidence in UltraTech Cement appears robust, with promoters holding 59.23% of the shares, indicating a strong commitment to the company’s long-term vision. Foreign institutional investors (FIIs) hold 15.33%, while domestic institutional investors (DIIs) account for 16.65%. This diversified shareholding structure suggests a healthy interest from both domestic and international investors. The increase in public shareholding to 8.55% also indicates growing retail participation. However, the slight decline in FIIs from their peak of 18.20% in December 2023 may warrant attention, as it could reflect changing investor sentiment or market conditions. Overall, the stable promoter holding coupled with institutional support paints a positive picture for investor confidence.
Outlook, Risks, and Final Insight
The outlook for UltraTech Cement hinges on several factors. The company’s ongoing expansion plans and its ability to manage rising costs will be crucial. While the demand for cement in India is expected to remain robust, supported by government infrastructure initiatives, potential risks include fluctuations in raw material prices and increased competition. As the market dynamics evolve, investors should closely monitor the company’s capacity to adapt to these changes. Additionally, the reduction in profitability margins could signal challenges ahead. For investors, UltraTech Cement represents a solid long-term play, but it’s essential to stay vigilant regarding its operational efficiencies and market positioning as they navigate these complexities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Bheema Cements Ltd | 52.7 Cr. | 16.2 | 22.4/16.2 | 0.60 | 0.00 % | 13.1 % | 108 % | 10.0 | |
| UltraTech Cement Ltd | 3,37,859 Cr. | 11,461 | 13,102/10,048 | 46.1 | 2,444 | 0.68 % | 10.9 % | 9.29 % | 10.0 |
| The Ramco Cements Ltd | 25,162 Cr. | 1,064 | 1,209/788 | 130 | 322 | 0.19 % | 4.83 % | 1.56 % | 1.00 |
| The India Cements Ltd | 13,354 Cr. | 431 | 447/239 | 325 | 0.00 % | 5.49 % | 8.83 % | 10.0 | |
| Star Cement Ltd | 8,719 Cr. | 216 | 309/196 | 28.8 | 74.4 | 0.46 % | 8.39 % | 6.05 % | 1.00 |
| Industry Average | 36,955.96 Cr | 1,859.18 | 37.18 | 573.47 | 0.55% | 8.79% | 85.81% | 7.13 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15,164 | 13,893 | 15,521 | 18,662 | 17,737 | 16,012 | 16,740 | 20,419 | 18,819 | 15,635 | 17,779 | 23,063 | 21,275 |
| Expenses | 12,069 | 12,028 | 13,185 | 15,340 | 14,688 | 13,461 | 13,485 | 16,305 | 15,801 | 13,618 | 14,885 | 18,456 | 16,869 |
| Operating Profit | 3,095 | 1,865 | 2,336 | 3,322 | 3,049 | 2,551 | 3,255 | 4,114 | 3,017 | 2,017 | 2,893 | 4,608 | 4,406 |
| OPM % | 20% | 13% | 15% | 18% | 17% | 16% | 19% | 20% | 16% | 13% | 16% | 20% | 21% |
| Other Income | 110 | 146 | 130 | 123 | 177 | 171 | 146 | 73 | 83 | 221 | 247 | 93 | 142 |
| Interest | 216 | 200 | 215 | 191 | 211 | 234 | 262 | 261 | 326 | 317 | 457 | 475 | 433 |
| Depreciation | 695 | 708 | 723 | 762 | 749 | 798 | 783 | 815 | 918 | 904 | 993 | 1,125 | 1,107 |
| Profit before tax | 2,293 | 1,103 | 1,527 | 2,492 | 2,267 | 1,690 | 2,355 | 3,111 | 1,857 | 1,017 | 1,691 | 3,101 | 3,008 |
| Tax % | 31% | 31% | 30% | 33% | 25% | 24% | 25% | 27% | 20% | 19% | 19% | 20% | 26% |
| Net Profit | 1,582 | 759 | 1,063 | 1,670 | 1,690 | 1,280 | 1,775 | 2,259 | 1,493 | 825 | 1,363 | 2,475 | 2,221 |
| EPS in Rs | 54.87 | 26.18 | 36.66 | 57.71 | 58.49 | 44.39 | 61.55 | 78.22 | 51.78 | 28.40 | 47.09 | 84.23 | 75.54 |
Last Updated: August 1, 2025, 9:50 am
Below is a detailed analysis of the quarterly data for UltraTech Cement Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 21,275.00 Cr.. The value appears to be declining and may need further review. It has decreased from 23,063.00 Cr. (Mar 2025) to 21,275.00 Cr., marking a decrease of 1,788.00 Cr..
- For Expenses, as of Jun 2025, the value is 16,869.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 18,456.00 Cr. (Mar 2025) to 16,869.00 Cr., marking a decrease of 1,587.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 4,406.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,608.00 Cr. (Mar 2025) to 4,406.00 Cr., marking a decrease of 202.00 Cr..
- For OPM %, as of Jun 2025, the value is 21.00%. The value appears strong and on an upward trend. It has increased from 20.00% (Mar 2025) to 21.00%, marking an increase of 1.00%.
- For Other Income, as of Jun 2025, the value is 142.00 Cr.. The value appears strong and on an upward trend. It has increased from 93.00 Cr. (Mar 2025) to 142.00 Cr., marking an increase of 49.00 Cr..
- For Interest, as of Jun 2025, the value is 433.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 475.00 Cr. (Mar 2025) to 433.00 Cr., marking a decrease of 42.00 Cr..
- For Depreciation, as of Jun 2025, the value is 1,107.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,125.00 Cr. (Mar 2025) to 1,107.00 Cr., marking a decrease of 18.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 3,008.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3,101.00 Cr. (Mar 2025) to 3,008.00 Cr., marking a decrease of 93.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Mar 2025) to 26.00%, marking an increase of 6.00%.
- For Net Profit, as of Jun 2025, the value is 2,221.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,475.00 Cr. (Mar 2025) to 2,221.00 Cr., marking a decrease of 254.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 75.54. The value appears to be declining and may need further review. It has decreased from 84.23 (Mar 2025) to 75.54, marking a decrease of 8.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 20,730 | 23,306 | 25,153 | 25,375 | 30,979 | 41,462 | 42,430 | 44,726 | 52,599 | 63,240 | 70,908 | 75,955 | 81,725 |
| Expenses | 16,695 | 18,881 | 20,252 | 20,162 | 24,834 | 34,115 | 33,184 | 33,158 | 41,084 | 52,620 | 57,930 | 63,158 | 66,729 |
| Operating Profit | 4,035 | 4,425 | 4,901 | 5,212 | 6,145 | 7,347 | 9,246 | 11,568 | 11,514 | 10,620 | 12,979 | 12,797 | 14,996 |
| OPM % | 19% | 19% | 19% | 21% | 20% | 18% | 22% | 26% | 22% | 17% | 18% | 17% | 18% |
| Other Income | 322 | 350 | 464 | 648 | 242 | 350 | 651 | 619 | 669 | 507 | 557 | 397 | 656 |
| Interest | 361 | 587 | 566 | 640 | 1,238 | 1,778 | 1,992 | 1,486 | 945 | 823 | 968 | 1,651 | 1,824 |
| Depreciation | 1,139 | 1,203 | 1,377 | 1,348 | 1,848 | 2,451 | 2,723 | 2,700 | 2,715 | 2,888 | 3,145 | 4,015 | 4,372 |
| Profit before tax | 2,858 | 2,986 | 3,421 | 3,872 | 3,301 | 3,468 | 5,183 | 8,001 | 8,524 | 7,416 | 9,422 | 7,528 | 9,456 |
| Tax % | 23% | 30% | 28% | 30% | 33% | 31% | -11% | 32% | 14% | 32% | 26% | 20% | |
| Net Profit | 2,213 | 2,102 | 2,480 | 2,714 | 2,224 | 2,400 | 5,751 | 5,462 | 7,334 | 5,073 | 7,004 | 6,040 | 7,297 |
| EPS in Rs | 80.44 | 76.47 | 90.30 | 98.90 | 80.92 | 87.51 | 199.40 | 189.26 | 254.42 | 175.41 | 242.65 | 204.94 | 248.65 |
| Dividend Payout % | 11% | 12% | 11% | 10% | 13% | 13% | 7% | 20% | 15% | 22% | 29% | 38% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -5.02% | 17.98% | 9.44% | -18.05% | 7.91% | 139.62% | -5.03% | 34.27% | -30.83% | 38.06% | -13.76% |
| Change in YoY Net Profit Growth (%) | 0.00% | 23.00% | -8.55% | -27.49% | 25.97% | 131.71% | -144.65% | 39.30% | -65.10% | 68.89% | -51.83% |
UltraTech Cement Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 13% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 1% |
| 3 Years: | -5% |
| TTM: | 0% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 26% |
| 3 Years: | 25% |
| 1 Year: | 10% |
| Return on Equity | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 12% |
| 3 Years: | 10% |
| Last Year: | 9% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 10, 2025, 3:35 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 274 | 274 | 274 | 275 | 275 | 275 | 289 | 289 | 289 | 289 | 289 | 295 | 295 |
| Reserves | 16,908 | 18,767 | 21,671 | 24,117 | 26,107 | 33,476 | 38,755 | 43,886 | 50,147 | 54,036 | 59,939 | 70,412 | 71,738 |
| Borrowings | 7,332 | 9,829 | 10,616 | 8,474 | 19,480 | 25,337 | 23,019 | 21,719 | 11,299 | 11,058 | 11,403 | 24,102 | 25,215 |
| Other Liabilities | 7,671 | 9,183 | 8,631 | 9,343 | 11,280 | 17,438 | 17,151 | 20,282 | 22,077 | 25,998 | 29,167 | 38,823 | 40,058 |
| Total Liabilities | 32,185 | 38,053 | 41,193 | 42,209 | 57,141 | 76,525 | 79,214 | 86,176 | 83,811 | 91,380 | 100,797 | 133,632 | 137,305 |
| Fixed Assets | 18,100 | 23,343 | 25,309 | 25,904 | 39,715 | 56,645 | 57,151 | 55,412 | 55,488 | 59,579 | 62,878 | 94,564 | 95,930 |
| CWIP | 2,186 | 2,250 | 1,469 | 921 | 1,511 | 1,153 | 920 | 1,687 | 4,785 | 4,040 | 6,811 | 6,234 | 7,206 |
| Investments | 4,862 | 4,500 | 5,095 | 6,691 | 5,447 | 2,921 | 5,929 | 12,178 | 6,336 | 7,297 | 8,249 | 5,156 | 5,098 |
| Other Assets | 7,037 | 7,961 | 9,319 | 8,693 | 10,468 | 15,806 | 15,215 | 16,900 | 17,203 | 20,464 | 22,859 | 27,677 | 29,072 |
| Total Assets | 32,185 | 38,053 | 41,193 | 42,209 | 57,141 | 76,525 | 79,214 | 86,176 | 83,811 | 91,380 | 100,797 | 133,632 | 137,305 |
Below is a detailed analysis of the balance sheet data for UltraTech Cement Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 295.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 295.00 Cr..
- For Reserves, as of Sep 2025, the value is 71,738.00 Cr.. The value appears strong and on an upward trend. It has increased from 70,412.00 Cr. (Mar 2025) to 71,738.00 Cr., marking an increase of 1,326.00 Cr..
- For Borrowings, as of Sep 2025, the value is 25,215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 24,102.00 Cr. (Mar 2025) to 25,215.00 Cr., marking an increase of 1,113.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 40,058.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 38,823.00 Cr. (Mar 2025) to 40,058.00 Cr., marking an increase of 1,235.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 137,305.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 133,632.00 Cr. (Mar 2025) to 137,305.00 Cr., marking an increase of 3,673.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 95,930.00 Cr.. The value appears strong and on an upward trend. It has increased from 94,564.00 Cr. (Mar 2025) to 95,930.00 Cr., marking an increase of 1,366.00 Cr..
- For CWIP, as of Sep 2025, the value is 7,206.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,234.00 Cr. (Mar 2025) to 7,206.00 Cr., marking an increase of 972.00 Cr..
- For Investments, as of Sep 2025, the value is 5,098.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,156.00 Cr. (Mar 2025) to 5,098.00 Cr., marking a decrease of 58.00 Cr..
- For Other Assets, as of Sep 2025, the value is 29,072.00 Cr.. The value appears strong and on an upward trend. It has increased from 27,677.00 Cr. (Mar 2025) to 29,072.00 Cr., marking an increase of 1,395.00 Cr..
- For Total Assets, as of Sep 2025, the value is 137,305.00 Cr.. The value appears strong and on an upward trend. It has increased from 133,632.00 Cr. (Mar 2025) to 137,305.00 Cr., marking an increase of 3,673.00 Cr..
Notably, the Reserves (71,738.00 Cr.) exceed the Borrowings (25,215.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -3.00 | -5.00 | -6.00 | -3.00 | -13.00 | -18.00 | -14.00 | -10.00 | 0.00 | -1.00 | 1.00 | -12.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 29 | 26 | 28 | 25 | 26 | 25 | 20 | 21 | 21 | 22 | 22 | 28 |
| Inventory Days | 251 | 266 | 203 | 195 | 226 | 214 | 234 | 207 | 256 | 248 | 255 | 255 |
| Days Payable | 252 | 154 | 142 | 150 | 165 | 165 | 188 | 234 | 269 | 271 | 260 | 248 |
| Cash Conversion Cycle | 28 | 138 | 89 | 70 | 87 | 74 | 66 | -6 | 9 | -0 | 17 | 35 |
| Working Capital Days | -20 | -82 | -83 | -38 | -50 | -48 | -60 | -83 | -56 | -56 | -52 | -64 |
| ROCE % | 12% | 12% | 13% | 14% | 12% | 10% | 12% | 15% | 14% | 13% | 15% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund | 2,103,927 | 3.12 | 2440.56 | 2,135,713 | 2025-12-15 08:36:05 | -1.49% |
| Kotak Flexicap Fund | 1,375,000 | 2.8 | 1595 | N/A | N/A | N/A |
| Axis Large Cap Fund | 826,535 | 2.81 | 958.78 | 843,367 | 2025-12-15 08:36:05 | -2% |
| Axis ELSS Tax Saver Fund | 697,445 | 2.31 | 809.04 | N/A | N/A | N/A |
| Nippon India Large Cap Fund | 625,475 | 1.44 | 725.55 | N/A | N/A | N/A |
| ICICI Prudential Business Cycle Fund | 395,118 | 2.92 | 458.34 | 401,113 | 2025-12-15 08:36:05 | -1.49% |
| ICICI Prudential Equity & Debt Fund | 390,187 | 0.92 | 452.62 | N/A | N/A | N/A |
| ICICI Prudential Multicap Fund | 368,008 | 2.64 | 426.89 | N/A | N/A | N/A |
| Kotak Large & Midcap Fund | 330,000 | 1.28 | 382.8 | N/A | N/A | N/A |
| HDFC Large Cap Fund | 324,934 | 0.93 | 376.92 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 205.30 | 243.05 | 175.63 | 254.64 | 189.40 |
| Diluted EPS (Rs.) | 205.13 | 242.87 | 175.54 | 254.53 | 189.33 |
| Cash EPS (Rs.) | 341.56 | 350.80 | 275.64 | 348.06 | 282.69 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 2399.42 | 2086.23 | 1883.69 | 1747.05 | 1530.59 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 2399.42 | 2086.23 | 1883.69 | 1747.05 | 1530.59 |
| Revenue From Operations / Share (Rs.) | 2577.55 | 2456.20 | 2190.58 | 1822.11 | 1549.48 |
| PBDIT / Share (Rs.) | 451.39 | 470.59 | 385.29 | 416.47 | 426.19 |
| PBIT / Share (Rs.) | 315.14 | 361.64 | 285.25 | 322.42 | 332.65 |
| PBT / Share (Rs.) | 255.83 | 325.62 | 256.75 | 289.70 | 272.14 |
| Net Profit / Share (Rs.) | 205.31 | 241.85 | 175.60 | 254.01 | 189.14 |
| NP After MI And SOA / Share (Rs.) | 204.94 | 242.65 | 175.41 | 254.42 | 189.26 |
| PBDIT Margin (%) | 17.51 | 19.15 | 17.58 | 22.85 | 27.50 |
| PBIT Margin (%) | 12.22 | 14.72 | 13.02 | 17.69 | 21.46 |
| PBT Margin (%) | 9.92 | 13.25 | 11.72 | 15.89 | 17.56 |
| Net Profit Margin (%) | 7.96 | 9.84 | 8.01 | 13.94 | 12.20 |
| NP After MI And SOA Margin (%) | 7.95 | 9.87 | 8.00 | 13.96 | 12.21 |
| Return on Networth / Equity (%) | 8.54 | 11.63 | 9.32 | 14.56 | 12.36 |
| Return on Capital Employeed (%) | 9.16 | 14.12 | 12.11 | 14.61 | 14.63 |
| Return On Assets (%) | 4.51 | 6.94 | 5.54 | 8.76 | 6.33 |
| Long Term Debt / Equity (X) | 0.22 | 0.08 | 0.09 | 0.10 | 0.30 |
| Total Debt / Equity (X) | 0.32 | 0.17 | 0.18 | 0.20 | 0.40 |
| Asset Turnover Ratio (%) | 0.64 | 0.73 | 0.71 | 0.60 | 0.54 |
| Current Ratio (X) | 0.73 | 0.86 | 0.88 | 0.86 | 1.17 |
| Quick Ratio (X) | 0.43 | 0.55 | 0.60 | 0.59 | 0.97 |
| Inventory Turnover Ratio (X) | 8.49 | 9.49 | 1.46 | 1.41 | 1.31 |
| Dividend Payout Ratio (NP) (%) | 33.40 | 15.63 | 21.57 | 14.52 | 6.86 |
| Dividend Payout Ratio (CP) (%) | 20.06 | 10.78 | 13.74 | 10.60 | 4.59 |
| Earning Retention Ratio (%) | 66.60 | 84.37 | 78.43 | 85.48 | 93.14 |
| Cash Earning Retention Ratio (%) | 79.94 | 89.22 | 86.26 | 89.40 | 95.41 |
| Interest Coverage Ratio (X) | 8.06 | 14.03 | 13.52 | 12.73 | 8.28 |
| Interest Coverage Ratio (Post Tax) (X) | 4.72 | 8.29 | 7.16 | 8.59 | 4.75 |
| Enterprise Value (Cr.) | 363558.87 | 290900.97 | 228788.60 | 200424.86 | 210253.91 |
| EV / Net Operating Revenue (X) | 4.79 | 4.10 | 3.62 | 3.81 | 4.70 |
| EV / EBITDA (X) | 27.33 | 21.41 | 20.57 | 16.67 | 17.09 |
| MarketCap / Net Operating Revenue (X) | 4.46 | 3.97 | 3.48 | 3.62 | 4.35 |
| Retention Ratios (%) | 66.59 | 84.36 | 78.42 | 85.47 | 93.13 |
| Price / BV (X) | 4.79 | 4.67 | 4.05 | 3.78 | 4.40 |
| Price / Net Operating Revenue (X) | 4.46 | 3.97 | 3.48 | 3.62 | 4.35 |
| EarningsYield | 0.01 | 0.02 | 0.02 | 0.03 | 0.02 |
After reviewing the key financial ratios for UltraTech Cement Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 205.30. This value is within the healthy range. It has decreased from 243.05 (Mar 24) to 205.30, marking a decrease of 37.75.
- For Diluted EPS (Rs.), as of Mar 25, the value is 205.13. This value is within the healthy range. It has decreased from 242.87 (Mar 24) to 205.13, marking a decrease of 37.74.
- For Cash EPS (Rs.), as of Mar 25, the value is 341.56. This value is within the healthy range. It has decreased from 350.80 (Mar 24) to 341.56, marking a decrease of 9.24.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,086.23 (Mar 24) to 2,399.42, marking an increase of 313.19.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 2,399.42. It has increased from 2,086.23 (Mar 24) to 2,399.42, marking an increase of 313.19.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 2,577.55. It has increased from 2,456.20 (Mar 24) to 2,577.55, marking an increase of 121.35.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 451.39. This value is within the healthy range. It has decreased from 470.59 (Mar 24) to 451.39, marking a decrease of 19.20.
- For PBIT / Share (Rs.), as of Mar 25, the value is 315.14. This value is within the healthy range. It has decreased from 361.64 (Mar 24) to 315.14, marking a decrease of 46.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 255.83. This value is within the healthy range. It has decreased from 325.62 (Mar 24) to 255.83, marking a decrease of 69.79.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 205.31. This value is within the healthy range. It has decreased from 241.85 (Mar 24) to 205.31, marking a decrease of 36.54.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 204.94. This value is within the healthy range. It has decreased from 242.65 (Mar 24) to 204.94, marking a decrease of 37.71.
- For PBDIT Margin (%), as of Mar 25, the value is 17.51. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 17.51, marking a decrease of 1.64.
- For PBIT Margin (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 14.72 (Mar 24) to 12.22, marking a decrease of 2.50.
- For PBT Margin (%), as of Mar 25, the value is 9.92. This value is below the healthy minimum of 10. It has decreased from 13.25 (Mar 24) to 9.92, marking a decrease of 3.33.
- For Net Profit Margin (%), as of Mar 25, the value is 7.96. This value is within the healthy range. It has decreased from 9.84 (Mar 24) to 7.96, marking a decrease of 1.88.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.95. This value is below the healthy minimum of 8. It has decreased from 9.87 (Mar 24) to 7.95, marking a decrease of 1.92.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.54. This value is below the healthy minimum of 15. It has decreased from 11.63 (Mar 24) to 8.54, marking a decrease of 3.09.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.16. This value is below the healthy minimum of 10. It has decreased from 14.12 (Mar 24) to 9.16, marking a decrease of 4.96.
- For Return On Assets (%), as of Mar 25, the value is 4.51. This value is below the healthy minimum of 5. It has decreased from 6.94 (Mar 24) to 4.51, marking a decrease of 2.43.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.22. This value is within the healthy range. It has increased from 0.08 (Mar 24) to 0.22, marking an increase of 0.14.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.32. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.32, marking an increase of 0.15.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.64. It has decreased from 0.73 (Mar 24) to 0.64, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 1.5. It has decreased from 0.86 (Mar 24) to 0.73, marking a decrease of 0.13.
- For Quick Ratio (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.55 (Mar 24) to 0.43, marking a decrease of 0.12.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 8.49. This value exceeds the healthy maximum of 8. It has decreased from 9.49 (Mar 24) to 8.49, marking a decrease of 1.00.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 33.40. This value is within the healthy range. It has increased from 15.63 (Mar 24) to 33.40, marking an increase of 17.77.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 20.06. This value is within the healthy range. It has increased from 10.78 (Mar 24) to 20.06, marking an increase of 9.28.
- For Earning Retention Ratio (%), as of Mar 25, the value is 66.60. This value is within the healthy range. It has decreased from 84.37 (Mar 24) to 66.60, marking a decrease of 17.77.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 79.94. This value exceeds the healthy maximum of 70. It has decreased from 89.22 (Mar 24) to 79.94, marking a decrease of 9.28.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 8.06. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 8.06, marking a decrease of 5.97.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 4.72. This value is within the healthy range. It has decreased from 8.29 (Mar 24) to 4.72, marking a decrease of 3.57.
- For Enterprise Value (Cr.), as of Mar 25, the value is 363,558.87. It has increased from 290,900.97 (Mar 24) to 363,558.87, marking an increase of 72,657.90.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.10 (Mar 24) to 4.79, marking an increase of 0.69.
- For EV / EBITDA (X), as of Mar 25, the value is 27.33. This value exceeds the healthy maximum of 15. It has increased from 21.41 (Mar 24) to 27.33, marking an increase of 5.92.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
- For Retention Ratios (%), as of Mar 25, the value is 66.59. This value is within the healthy range. It has decreased from 84.36 (Mar 24) to 66.59, marking a decrease of 17.77.
- For Price / BV (X), as of Mar 25, the value is 4.79. This value exceeds the healthy maximum of 3. It has increased from 4.67 (Mar 24) to 4.79, marking an increase of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.46. This value exceeds the healthy maximum of 3. It has increased from 3.97 (Mar 24) to 4.46, marking an increase of 0.49.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in UltraTech Cement Ltd:
- Net Profit Margin: 7.96%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.16% (Industry Average ROCE: 8.79%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.54% (Industry Average ROE: 85.81%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 4.72
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.43
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.1 (Industry average Stock P/E: 37.18)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.32
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.96%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Cement | 'B' Wing, Ahura Centre, 2nd Foor, Mumbai Maharashtra 400093 | sharesutcl@adityabirla.com http://www.ultratechcement.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Kumar Mangalam Birla | Chairman & Non-Exe.Director |
| Mr. K K Maheshwari | Vice Chairman & Non Exe.Dire |
| Mr. K C Jhanwar | Managing Director |
| Mrs. Rajashree Birla | Non Executive Director |
| Mrs. Alka Bharucha | Independent Director |
| Mr. Sunil Duggal | Independent Director |
| Mr. Vivek Agrawal | Whole Time Director |
| Mr. Anjani Agrawal | Independent Director |
| Dr. Vikas Balia | Independent Director |
| Ms. Anita Ramachandran | Independent Director |
FAQ
What is the intrinsic value of UltraTech Cement Ltd?
UltraTech Cement Ltd's intrinsic value (as of 18 December 2025) is 8430.46 which is 26.44% lower the current market price of 11,461.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 3,37,859 Cr. market cap, FY2025-2026 high/low of 13,102/10,048, reserves of ₹71,738 Cr, and liabilities of 137,305 Cr.
What is the Market Cap of UltraTech Cement Ltd?
The Market Cap of UltraTech Cement Ltd is 3,37,859 Cr..
What is the current Stock Price of UltraTech Cement Ltd as on 18 December 2025?
The current stock price of UltraTech Cement Ltd as on 18 December 2025 is 11,461.
What is the High / Low of UltraTech Cement Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of UltraTech Cement Ltd stocks is 13,102/10,048.
What is the Stock P/E of UltraTech Cement Ltd?
The Stock P/E of UltraTech Cement Ltd is 46.1.
What is the Book Value of UltraTech Cement Ltd?
The Book Value of UltraTech Cement Ltd is 2,444.
What is the Dividend Yield of UltraTech Cement Ltd?
The Dividend Yield of UltraTech Cement Ltd is 0.68 %.
What is the ROCE of UltraTech Cement Ltd?
The ROCE of UltraTech Cement Ltd is 10.9 %.
What is the ROE of UltraTech Cement Ltd?
The ROE of UltraTech Cement Ltd is 9.29 %.
What is the Face Value of UltraTech Cement Ltd?
The Face Value of UltraTech Cement Ltd is 10.0.